Rwanda president Paul Kagame and BioNTech CEO Uğur Şahin (via BioNTech)

BioN­Tech breaks ground on first mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty in Africa

Covid vac­cine ac­cess to low­er- and mid­dle-in­come na­tions has been a con­cern dur­ing the length of the pan­dem­ic, but BioN­Tech is now push­ing for­ward with plans to in­crease vac­cine ac­cess for Africa.

Con­struc­tion work has kicked off for an mR­NA man­u­fac­tur­ing fa­cil­i­ty in Ki­gali, Rwan­da. Ac­cord­ing to BioN­Tech, the fa­cil­i­ty, dubbed the African mod­u­lar mR­NA man­u­fac­tur­ing fa­cil­i­ty, has a tar­get for the first set of man­u­fac­tur­ing tools to be de­liv­ered to the site by the end of this year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.